Triple
T5248761
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | AstraZeneca |
E118527
|
entity |
| Predicate | notableProduct |
P1448
|
FINISHED |
| Object |
Imfinzi
Imfinzi is a prescription immunotherapy drug (durvalumab) developed by AstraZeneca, primarily used to treat certain types of lung and bladder cancers by helping the immune system attack cancer cells.
|
E505480
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69bd4468aacc8190a8196f71855cdf4f |
elicitation | completed |
| NER | batch_69bd7b787b34819081af96de9355bb4f |
ner | completed |
| NED1 | batch_69bef83998f881909fef2746f5c496af |
ned_source_triple | completed |
| NED2 | batch_69befac54e8c8190986aca0f5591d04e |
ned_description | completed |
| NEDg | batch_69befa746be88190a8d807317ab36430 |
nedg | completed |
Created at: March 20, 2026, 1:50 p.m.